Correlation of estrogen receptor and pathologic characteristics of invasive breast cancer
Open Access
- 15 January 1980
- Vol. 45 (2) , 349-353
- https://doi.org/10.1002/1097-0142(19800115)45:2<349::aid-cncr2820450226>3.0.co;2-p
Abstract
Estrogen receptor (ER) status was correlated with a large number of pathological and clinical characteristics of 178 invasive breast cancers. Positive ER was found to be significantly associated with high nuclear and low histologic grades, absence of tumor necrosis, presence of marked tumor elastosis, and older patients. These pathologic parameters enumerated are either directly or indirectly related to tumor differentiation suggesting that ER represents another index of this latter. Multivariate analyses disclosed that both age and tumor differentiation are associated with the ER status. Well‐differentiated tumors were more frequently ER+ in older women. Inclusion of an estimate of tumor necrosis as well as patient age appears to allow for further discrimination of ER status in poorly differentiated lesions. Considerations relative to ER and tumor differentiation provide a possible explanation for the dichotomy of response to adjuvant chemotherapy observed in pre and postmenopausal women.This publication has 15 references indexed in Scilit:
- What Does Laboratory “Quality Control” Really Control?New England Journal of Medicine, 1978
- Pathological findings from the national surgical adjuvant breast project (protocol no. 4). IV. Significance of tumor necrosisHuman Pathology, 1978
- The Relation between Estrogen Receptors and Response Rate to Cytotoxic Chemotherapy in Metastatic Breast CancerNew England Journal of Medicine, 1978
- Factors affecting estrogen receptors in breast cancerCancer, 1977
- The CMF program for operable breast cancer with positive axillary nodes:Updated analysis on the disease-free interval, site of relapse and drug toleranceCancer, 1977
- L-phenylalanine mustard (L-PAM) in the management of primary breast cancer:An update of earlier findings and a comparison with those utilizing L-PAM plus 5-fluorouracil (5-FU)Cancer, 1977
- Current status of estrogen and progesterone receptors in breast cancerCancer, 1977
- Elastosis and oestrogen receptors in human breast cancerBritish Journal of Cancer, 1976
- Pathologic Findings from the National Surgical Adjuvant Breast Project (Protocol No. 4): II. The Significance of Regional Node Histology Other Than Sinus Histiocytosis in Invasive Mammary CancerAmerican Journal of Clinical Pathology, 1976
- The pathology of invasive breast cancerA Syllabus Derived from Findings of the National Surgical Adjuvant Breast Project (Protocol No. 4)Cancer, 1975